GlaxoSmithKline PLC GSK-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 4:35 PM GMT
1,591.80quote price arrow up+16.00 (+1.01%)
52 week range
1,190.80 - 1,604.40
Loading...
  • Open1,582.00
  • Day High1,595.20
  • Day Low1,576.20
  • Prev Close1,575.80
  • 52 Week High1,604.40
  • 52 Week High Date11/12/21
  • 52 Week Low1,190.80
  • 52 Week Low Date02/26/21

Key Stats

  • Market Cap102,410.01M
  • Shares Out5,031.74M
  • 10 Day Average Volume7.53M
  • Dividend80.00
  • Dividend Yield5.03%
  • Beta0.6
  • YTD % Change18.61

KEY STATS

  • Open1,582.00
  • Day High1,595.20
  • Day Low1,576.20
  • Prev Close1,575.80
  • 52 Week High1,604.40
  • 52 Week High Date11/12/21
  • 52 Week Low1,190.80
  • 52 Week Low Date02/26/21
  • Market Cap102,410.01M
  • Shares Out5,031.74M
  • 10 Day Average Volume7.53M
  • Dividend80.00
  • Dividend Yield5.03%
  • Beta0.6
  • YTD % Change18.61

RATIOS/PROFITABILITY

  • EPS (TTM)86.29
  • P/E (TTM)18.45
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date11/18/2021
  • Div Amount19.00
  • Split Date-
  • Split Factor-

Content From Our Affiliates

Related Video

VIDEO2:4202:42
Pfizer, PayPal, and more: CNBC's 'Halftime Report' traders answer your questions

Profile

MORE
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a...
Jonathan Symonds CBE
Non-Executive Chairman
Emma Walmsley
Chief Executive Officer
Iain Mackay
Chief Financial Officer
Address
G S K House, 980 Great West Road
Brentford
TW8 9GS
United Kingdom